Raffaele Costanzo

Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours

Michele Caraglia, Raffaele Addeo, Raffaele Costanzo et al. · Cancer Chemotherapy and Pharmacology · 2005 · 68 citations

Medicine, Oncology, Pharmacology +16

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials

Cesare Gridelli, Alessandro Morabito, Luigi Cavanna et al. · Journal of Clinical Oncology · 2018 · 68 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

Maria Carmela Piccirillo, Laura Bonanno, Marina Chiara Garassino et al. · Journal of Thoracic Oncology · 2022 · 68 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +9

Prognostic value of circulating tumor cells’ reduction in patients with extensive small-cell lung cancer

Nicola Normanno, Antônio Rossi, Alessandro Morabito et al. · Lung Cancer · 2014 · 67 citations

Medicine, Cancer Biology, Oncology +16

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study

Alessandro Morabito, Vittorio Gebbia, Massimo Di Maïo et al. · Lung Cancer · 2013 · 56 citations

Medicine, Oncology, Chemotherapy +12